Apotex Appeals Plavix Injunction To Federal Circuit
Generic drug maker Apotex Inc. filed an appeal on Wednesday against the injunction that is prohibiting it from selling generic Plavix until patent litigation with Bristol-Myers Squibb and Sanofi-Aventis is resolved....To view the full article, register now.
Already a subscriber? Click here to view full article